APO RESEARCH · REPORT
Breast Cancer Screening
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
Product & engineering
Understand the product.
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
Selected research
Industry Research
Breast Cancer Screening Industry Research Report 2026
Market perspective
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.
Read the full market overview
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.
Report Scope
This report quantifies the global Breast Cancer Screening market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Breast Cancer Screening Market by Company
Hologic
GE Healthcare
Siemen Healthineers
Philips Healthcare
Canon Medical
Fujifilm
Metaltronica
Sino Medical-Device
IMS Srl
Breast Cancer Screening Segment by Type
Mammography Screening
Breast Magnetic Resonance Imaging (MRI) Screening
Breast Ultrasound Screening
Breast Cancer Screening Segment by Application
Hospital
Clinic
Breast Cancer Screening Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast Cancer Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Breast Cancer Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast Cancer Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Breast Cancer Screening manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Breast Cancer Screening by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Breast Cancer Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mammography Screening
- Breast Magnetic Resonance Imaging (MRI) Screening
- Breast Ultrasound Screening
Applications
- Hospital
- Clinic
Companies covered
- Hologic
- GE Healthcare
- Siemen Healthineers
- Philips Healthcare
- Canon Medical
- Fujifilm
- Metaltronica
- Sino Medical-Device
- IMS Srl
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Breast Cancer Screening Market Size (2021-2032)
- 2.2.2 Global Breast Cancer Screening Sales (2021-2032)
- 2.2.3 Global Breast Cancer Screening Market Average Price (2021-2032)
- 2.3 Breast Cancer Screening by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mammography Screening
- 2.3.3 Breast Magnetic Resonance Imaging (MRI) Screening
- 2.3.4 Breast Ultrasound Screening
- 2.4 Breast Cancer Screening by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Breast Cancer Screening Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Breast Cancer Screening Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Breast Cancer Screening Revenue of Manufacturers (2021-2026)
- 3.4 Global Breast Cancer Screening Average Price by Manufacturers (2021-2026)
- 3.5 Global Breast Cancer Screening Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Breast Cancer Screening, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Breast Cancer Screening, Product Type & Application
- 3.8 Global Manufacturers of Breast Cancer Screening, Established Date
- 3.9 Global Breast Cancer Screening Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hologic
- 4.1.1 Hologic Company Information
- 4.1.2 Hologic Business Overview
- 4.1.3 Hologic Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hologic Breast Cancer Screening Product Portfolio
- 4.1.5 Hologic Recent Developments
- 4.2 GE Healthcare
- 4.2.1 GE Healthcare Company Information
- 4.2.2 GE Healthcare Business Overview
- 4.2.3 GE Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GE Healthcare Breast Cancer Screening Product Portfolio
- 4.2.5 GE Healthcare Recent Developments
- 4.3 Siemen Healthineers
- 4.3.1 Siemen Healthineers Company Information
- 4.3.2 Siemen Healthineers Business Overview
- 4.3.3 Siemen Healthineers Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Siemen Healthineers Breast Cancer Screening Product Portfolio
- 4.3.5 Siemen Healthineers Recent Developments
- 4.4 Philips Healthcare
- 4.4.1 Philips Healthcare Company Information
- 4.4.2 Philips Healthcare Business Overview
- 4.4.3 Philips Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Philips Healthcare Breast Cancer Screening Product Portfolio
- 4.4.5 Philips Healthcare Recent Developments
- 4.5 Canon Medical
- 4.5.1 Canon Medical Company Information
- 4.5.2 Canon Medical Business Overview
- 4.5.3 Canon Medical Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Canon Medical Breast Cancer Screening Product Portfolio
- 4.5.5 Canon Medical Recent Developments
- 4.6 Fujifilm
- 4.6.1 Fujifilm Company Information
- 4.6.2 Fujifilm Business Overview
- 4.6.3 Fujifilm Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fujifilm Breast Cancer Screening Product Portfolio
- 4.6.5 Fujifilm Recent Developments
- 4.7 Metaltronica
- 4.7.1 Metaltronica Company Information
- 4.7.2 Metaltronica Business Overview
- 4.7.3 Metaltronica Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Metaltronica Breast Cancer Screening Product Portfolio
- 4.7.5 Metaltronica Recent Developments
- 4.8 Sino Medical-Device
- 4.8.1 Sino Medical-Device Company Information
- 4.8.2 Sino Medical-Device Business Overview
- 4.8.3 Sino Medical-Device Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sino Medical-Device Breast Cancer Screening Product Portfolio
- 4.8.5 Sino Medical-Device Recent Developments
- 4.9 IMS Srl
- 4.9.1 IMS Srl Company Information
- 4.9.2 IMS Srl Business Overview
- 4.9.3 IMS Srl Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 IMS Srl Breast Cancer Screening Product Portfolio
- 4.9.5 IMS Srl Recent Developments
5 Global Breast Cancer Screening Market Scenario by Region
- 5.1 Global Breast Cancer Screening Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Breast Cancer Screening Sales by Region: 2021-2032
- 5.2.1 Global Breast Cancer Screening Sales by Region: 2021-2026
- 5.2.2 Global Breast Cancer Screening Sales by Region: 2027-2032
- 5.3 Global Breast Cancer Screening Revenue by Region: 2021-2032
- 5.3.1 Global Breast Cancer Screening Revenue by Region: 2021-2026
- 5.3.2 Global Breast Cancer Screening Revenue by Region: 2027-2032
- 5.4 North America Breast Cancer Screening Market Facts & Figures by Country
- 5.4.1 North America Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Breast Cancer Screening Sales by Country (2021-2032)
- 5.4.3 North America Breast Cancer Screening Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Breast Cancer Screening Market Facts & Figures by Country
- 5.5.1 Europe Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Breast Cancer Screening Sales by Country (2021-2032)
- 5.5.3 Europe Breast Cancer Screening Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Breast Cancer Screening Market Facts & Figures by Country
- 5.6.1 Asia Pacific Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Breast Cancer Screening Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Breast Cancer Screening Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Breast Cancer Screening Market Facts & Figures by Country
- 5.7.1 South America Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Breast Cancer Screening Sales by Country (2021-2032)
- 5.7.3 South America Breast Cancer Screening Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Breast Cancer Screening Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Breast Cancer Screening Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Breast Cancer Screening Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Breast Cancer Screening Sales by Type (2021-2032)
- 6.1.1 Global Breast Cancer Screening Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Breast Cancer Screening Sales Market Share by Type (2021-2032)
- 6.2 Global Breast Cancer Screening Revenue by Type (2021-2032)
- 6.2.1 Global Breast Cancer Screening Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Breast Cancer Screening Revenue Market Share by Type (2021-2032)
- 6.3 Global Breast Cancer Screening Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Breast Cancer Screening Sales by Application (2021-2032)
- 7.1.1 Global Breast Cancer Screening Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Breast Cancer Screening Sales Market Share by Application (2021-2032)
- 7.2 Global Breast Cancer Screening Revenue by Application (2021-2032)
- 7.2.1 Global Breast Cancer Screening Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Breast Cancer Screening Revenue Market Share by Application (2021-2032)
- 7.3 Global Breast Cancer Screening Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Breast Cancer Screening Value Chain Analysis
- 8.1.1 Breast Cancer Screening Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Breast Cancer Screening Production Mode & Process
- 8.2 Breast Cancer Screening Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Breast Cancer Screening Distributors
- 8.2.3 Breast Cancer Screening Customers
9 Global Breast Cancer Screening Analyzing Market Dynamics
- 9.1 Breast Cancer Screening Industry Trends
- 9.2 Breast Cancer Screening Industry Drivers
- 9.3 Breast Cancer Screening Industry Opportunities and Challenges
- 9.4 Breast Cancer Screening Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst